Lauren Merendino

2021

In 2021, Lauren Merendino earned a total compensation of $3.5M as Chief Commercial Officer at Myovant Sciences Ltd..

Compensation breakdown

Non-Equity Incentive Plan$175,000
Option Awards$1,425,545
Salary$461,721
Stock Awards$1,399,986
Other$1,425
Total$3,463,677

Merendino received $1.4M in option awards, accounting for 41% of the total pay in 2021.

Merendino also received $175K in non-equity incentive plan, $461.7K in salary, $1.4M in stock awards and $1.4K in other compensation.

Rankings

In 2021, Lauren Merendino's compensation ranked 3,865th out of 12,415 executives tracked by ExecPay. In other words, Merendino earned more than 68.9% of executives.

ClassificationRankingPercentile
All
3,865
out of 12,415
69th
Division
Manufacturing
1,583
out of 5,505
71st
Major group
Chemicals And Allied Products
647
out of 2,375
73rd
Industry group
Drugs
575
out of 2,096
73rd
Industry
Pharmaceutical Preparations
402
out of 1,546
74th
Source: SEC filing on July 27, 2022.

Merendino's colleagues

We found three more compensation records of executives who worked with Lauren Merendino at Myovant Sciences Ltd. in 2021.

2021

David Marek

Myovant Sciences Ltd.

Principal Executive Officer

2021

Uneek Mehra

Myovant Sciences Ltd.

Principal Financial Officer

2021

Frank Karbe

Myovant Sciences Ltd.

Former Principal Financial and Accounting Officer

News

You may also like